ecancermedicalscience

Erratum

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

7 Aug 2020
Fernando Petracci, Gonzalo Gomez Abuin, Alejandra Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect:

'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, 40.6% PR and 40.6% SD. In second line the ORR were: 25% PR, 37.5% SD and no CR.'

Related Articles

Sandy Minck, Gerda Evans, Marie Lowe, Cindy Schultz-Ferguson, Catherine Woulfe, Kym Berchtenbreiter, Krysty Sullivan, Ann White, Lynette Moore, Susan Jarvis, Wendy V Ingman, Jennifer Stone
Abeir El-Mogassabi, Heithum Saleh Baiu, Nadin Omer Hassan, Enas Mohamed Salem, Lugien Elshakmak, Khalil A K Tamoos, Mohammed Zidan, Asma Rajab Ben Rashid, Ala Elhoudiri, Sama Elmehdawi, Dania Shareia
Md Foorquan Hashmi, Fiza Khan, Elen Baloyan, Liana Safaryan, Davit Zohrabyan, Gevorg Tamamyan, Samvel Bardakhchyan
Oluwafemi E Adesina, Oluwadamilare Akingbade, Emmanuel O Adesuyi, Yetunde Tola, Ooreofe Bolanle Adeyemi, Tosin Akintunde, Stephan Osei, Julius Maitanmi, Deborah T Esan
Gabriel Berlingieri Polho, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Diana del Cisne Pineda Labanda, Yumi Ricucci Shinkado, Romualdo Barroso-Sousa, Luciana Rodrigues Carvalho Barros, Laura Testa, Renata Colombo Bonadio